TSNLF (Tristel) Marketable Securities: $8.34 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSNLF Tristel PLC TSNLF
95 GF Score
Price $5.28
GF Value $6.09
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Tristel Marketable Securities?

Tristel TSNLF 95 Marketable Securities is $8.34 Mil as of Dec. 2025. GuruFocus rates TSNLF with a GF Score™ of 95/100 and a GF Value™ of $6.09 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Tristel's Marketable Securities for the quarter that ended in Dec. 2025 was $8.34 Mil.

Tristel's annual Marketable Securities increased from Jun. 2023 ($3.07 Mil) to Jun. 2024 ($7.19 Mil) but then declined from Jun. 2024 ($7.19 Mil) to Jun. 2025 ($5.70 Mil).

Tristel  (OTCPK:TSNLF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Tristel Marketable Securities Related Terms

Tristel Marketable Securities Historical Data

* Premium members only.

The historical data trend for Tristel's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tristel Marketable Securities Chart

Tristel Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 3.07 7.19 5.70

Tristel Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.60 7.19 0.00 5.70 8.34
TSNLF
95GF Score
Tristel PLC TSNLF
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tristel Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $8.34 Mil mean?
Tristel (TSNLF) has a Marketable Securities of $8.34 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Tristel and its competitors.
Is Tristel's Marketable Securities too high?
Tristel's current Marketable Securities is $8.34 Mil. Overall, Tristel has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tristel's Marketable Securities compare to ISRG and BDX?
Tristel's Marketable Securities of $8.34 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Tristel and its competitors. Tristel's current Marketable Securities is $8.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tristel stock overvalued right now?
Based on GuruFocus' analysis, Tristel (TSNLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.09, compared to a current price of $5.28 — trading 13.3% below its estimated fair value. The current Marketable Securities is $8.34 Mil. Tristel's overall GF Score™ is 95/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Tristel (TSNLF), the current Marketable Securities is $8.34 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tristel (TSNLF) Overvalued in 2026?

Based on GuruFocus' analysis, Tristel stock appears to be undervalued. The current stock price of $5.28 is trading 13.3% below its estimated GF Value™ of $6.09. GuruFocus considers Tristel to be Modestly Undervalued.

Key valuation signals for TSNLF:

  • Marketable Securities: $8.34 Mil
  • GF Value™: $6.09 vs. price of $5.28 (13.3% below fair value)
  • GF Score™: 95/100 with 1 warning sign

No single metric tells the full story. See the TSNLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tristel Business Description

Other Exchanges TSTL:UKR1V:Germany
Address Fordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, Cambridgeshire, GBR, CB8 7NY
Tristel PLC's business is the sale to hospitals of its proprietary chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand and for the sporicidal disinfection of environmental surfaces under the Cache brand. Its operating segments include hospital medical device decontamination products used predominantly for infection control in hospitals; the manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates the majority of its revenue from hospital medical device decontamination and operates geographically in the UK and overseas markets.
95GF Score

Get the complete analysis for TSNLF

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.28
Price
$6.09
GF Value